Giorgio V. Scagliotti, MD | Authors


Molecular Profiling to Inform Treatment Decisions for Patients With NSCLC

July 27, 2018

Giorgio Vittorio Scagliotti, MD, PhD, chief of the Medical Oncology Division at the S. Luigi Hospital, Orbassano (Torino), and head of the Department of Oncology at University of Torino, Italy, discusses the utilization of molecular profiling to inform treatment decisions for patients with non-small cell lung cancer.